• Dr. Reddy’s Lab’s consolidated revenues for the quarter ended March (Q4FY22) were up 3.8% quarter-on-quarter (QoQ). On a year-on-year (YoY) basis, it witnessed a growth of 15.4%.
  • Its expenses for the quarter were up 20.5% QoQ and 31.9% YoY.
  • The earnings per share (EPS) of Dr. Reddy’s Lab stood at 5.8 during Q4FY22.

Dr. Reddy’s Lab’s Financial Statements for Q4FY22:

(Rs, crores) Q4FY21 Q3FY22 Q4FY22 QoQ (%) YoY (%)
Total Income 4,851 5,394 5,597 3.8% 15.4%
Total Expenses 4,054 4,438 5,348 20.5% 31.9%
Profit before tax 815 974 259 -73.4% -68.2%
Tax 258 265 162 -38.9% -37.2%
Profit after tax 557 709 97 -86.3% -82.6%
Earnings per share 33.5 42.7 5.8    

Data Source: BSE, Company announcements

Want to keep a tab on Indian listed companies? Open an account and get daily stock research updates from Kotak Securities.

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results